Antigen/platform pairings (“Forget Wine and Cheese…Get this Right and Your Valuation Takes Flight”)

Advanced Therapeutics
Wednesday, May 6, 2020 | 9:00 – 10:15 am


  • Joel S. Sandler, PhD, Associate Principal, Cello Health BioConsulting, previously Defined Health


  • Sharon Benzeno, PhD, MBA, SVP Drug Discovery, Adaptive Biotechnologies Corp
  • Stephen Eck, MD, PhD, Chief Medical Officer, Immatics US
  • Dora Mitchell, PhD, VP Business Development, Carisma Therapeutics Inc.
  • Travis Quigley, VP, Clinical Development, Arcellx, Inc.
  • Henry Rath, CBO, TScan Therapeutics
  • Stephen Rubino, PhD, CBO, Celyad
  • Ian Somaiya, CFO, TCR2 Therapeutics Inc.